» Articles » PMID: 36997927

Endometrioid Adenocarcinoma Arising in Adenomyosis in a Patient with Pelvic Organ Prolapse-case Report

Overview
Publisher Biomed Central
Date 2023 Mar 30
PMID 36997927
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Adenomyosis is a frequent finding in endometrial carcinoma patients. Endometrioid adenocarcinoma is the most common type of endometrial carcinoma; however, endometrioid adenocarcinoma arising from adenomyosis is extremely rare.

Case Presentation: In this case report, we describe a 69-year-old woman who required surgical treatment for pelvic organ prolapse (POP). The patient had been postmenopausal for 20 years and had no abnormal bleeding after menopause. The patient underwent transvaginal hysterectomy, repair of anterior and posterior vaginal walls, ischium fascial fixation and repair of an old perineal laceration. Histological examination of surgical specimens revealed endometrioid adenocarcinoma of the uterus. Bilateral adnexectomy, pelvic lymphadenectomy and para-aortic lymphadenectomy were then performed. The postoperative histopathological diagnosis was stage IB endometrial cancer (endometrioid carcinoma G2).

Conclusions: In summary, endometrioid adenocarcinoma arising from adenomyosis (EC-AIA) is a rare entity and the early diagnosis is difficult. Adequate preoperative assessment and enhanced inquiry of occult clinical symptoms of postmenopausal women before hysterectomy may contribute to the diagnosis of EC-AIA preoperatively.

Citing Articles

Whether surgical procedure can improve the prognosis of endometrial cancer arising in adenomyosis (EC-AIA)? A systematic review and meta-analysis.

Sun Y, Lin S, Wu W, Nie F, Liu Y, Wen J Int J Surg. 2024; 110(5):3072-3080.

PMID: 38445439 PMC: 11093450. DOI: 10.1097/JS9.0000000000001234.


Clinical Characteristics and Local Histopathological Modulators of Endometriosis and Its Progression.

Istrate-Ofiteru A, Mogoanta C, Zorila G, Rosu G, Dragusin R, Berbecaru E Int J Mol Sci. 2024; 25(3).

PMID: 38339066 PMC: 10855449. DOI: 10.3390/ijms25031789.


Adenomyosis and Its Possible Malignancy: A Review of the Literature.

Moraru L, Mitranovici M, Chiorean D, Moraru R, Caravia L, Tiron A Diagnostics (Basel). 2023; 13(11).

PMID: 37296736 PMC: 10252751. DOI: 10.3390/diagnostics13111883.

References
1.
Habiba M, Pluchino N, Petignat P, Bianchi P, Brosens I, Benagiano G . Adenomyosis and Endometrial Cancer: Literature Review. Gynecol Obstet Invest. 2018; 83(4):313-328. DOI: 10.1159/000487320. View

2.
Matsuo K, Moeini A, Machida H, Scannell C, Casabar J, Kakuda M . Tumor Characteristics and Survival Outcome of Endometrial Cancer Arising in Adenomyosis: An Exploratory Analysis. Ann Surg Oncol. 2015; 23(3):959-67. PMC: 7521605. DOI: 10.1245/s10434-015-4952-y. View

3.
COLMAN H, ROSENTHAL A . Carcinoma developing in areas of adenomyosis. Obstet Gynecol. 1959; 14:342-8. View

4.
Oaknin A, Bosse T, Creutzberg C, Giornelli G, Harter P, Joly F . Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022; 33(9):860-877. DOI: 10.1016/j.annonc.2022.05.009. View

5.
Khalifa M, Atri M, Klein M, Ghatak S, Murugan P . Adenomyosis As a Confounder to Accurate Endometrial Cancer Staging. Semin Ultrasound CT MR. 2019; 40(4):358-363. DOI: 10.1053/j.sult.2019.04.004. View